Internal Medicine, Hematology & Oncology · Tallahassee, FL
NPI
1699905364
Since 2009
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1775 One Healing Pl Fl 2
Tallahassee, FL, 32308
Phone (850) 431-5360
Groups this clinician bills Medicare through
Medicare paid, 2024
$128K
1,113 services
Medicare patients, 2024
287
Average age 74
Drug cost, 2024
$5.7M
2,053 prescriptions
Company payments, 2024
$22.47
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mitchell F Peabody was code 99214 (office e&m - established), 611 times for 207 patients. In total Mitchell F Peabody billed 1,113 services in 11 codes, and Medicare paid $128K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-03-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 611 | 207 | $97.24 | $59K |
| 99215 Office E&M - Established | Office | 329 | 67 | $147.09 | $48K |
| 99205 Office E&M - New | Office | 54 | 54 | $170.01 | $9,181 |
| 99213 Office E&M - Established | Office | 36 | 30 | $66.31 | $2,387 |
| 99232 Hospital E&M - Subsequent | Facility | 27 | 13 | $66.47 | $1,795 |
| 99223 Hospital E&M - Initial | Facility | 23 | 20 | $146.09 | $3,360 |
| 99233 Hospital E&M - Subsequent | Facility | 17 | 11 | $99.94 | $1,699 |
By year: 2022 $109K for 1,021 services; 2023 $98K for 968 services; 2024 $128K for 1,113 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mitchell F Peabody prescribed most often to Medicare patients was Anastrozole, with 383 prescriptions and refills. In total Mitchell F Peabody wrote 2,053 Medicare prescriptions that cost $5.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 383 | 960 | 103 | $11K |
| Eliquis Apixaban | 119 | 151 | 22 | $85K |
| Oxycodone Hcl Generic | 62 | 62 | 24 | $1,214 |
| Letrozole Generic | 61 | 118 | 13 | $1,141 |
| Levothyroxine Sodium Generic | 60 | 108 | 14 | $306 |
| Gabapentin Generic | 59 | 67 | 11 | $1,419 |
| Ondansetron Odt Ondansetron | 57 | 64 | 46 | $2,961 |
| Hydroxyurea Generic | 55 | 113 | 13 | $2,011 |
| Prochlorperazine Maleate Generic | 51 | 51 | 37 | $1,535 |
| Xtandi Enzalutamide | 51 | 51 | Under 11 | $700K |
| Brukinsa Zanubrutinib | 49 | 49 | Under 11 | $552K |
| Potassium Chloride Generic | 46 | 64 | 15 | $1,044 |
| Ibrance Palbociclib | 43 | 43 | Under 11 | $725K |
| Dexamethasone Generic | 42 | 51 | 11 | $659 |
| Imbruvica Ibrutinib | 41 | 41 | Under 11 | $655K |
Brand drugs: 506 claims; generic drugs: 1,547 claims; opioid claims: 201.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Mitchell F Peabody $22.47 ($22.47 in general payments such as food, travel and fees) from 1 company. The largest payer was Sirtex Medical Inc with $22.47.
| Company | Payments | Amount |
|---|---|---|
| Sirtex Medical Inc | 1 | $22.47 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.